BACKGROUND: The literature on associations of circulating concentrations of minerals and vitamins with risk of colorectal cancer is limited and inconsistent. Evidence from randomized controlled trials (RCTs) to support the efficacy of dietary modification or nutrient supplementation for colorectal cancer prevention is also limited. OBJECTIVES: To complement observational and RCT findings, we investigated associations of genetically predicted concentrations of 11 micronutrients (β-carotene, calcium, copper, folate, iron, magnesium, phosphorus, selenium, vitamin B-6, vitamin B-12, and zinc) with colorectal cancer risk using Mendelian randomization (MR). METHODS: Two-sample MR was conducted using 58,221 individuals with colorectal cancer and 67,694 controls from the Genetics and Epidemiology of Colorectal Cancer Consortium, Colorectal Cancer Transdisciplinary Study, and Colon Cancer Family Registry. Inverse variance-weighted MR analyses were performed with sensitivity analyses to assess the impact of potential violations of MR assumptions. RESULTS: Nominally significant associations were noted for genetically predicted iron concentration and higher risk of colon cancer [ORs per SD (ORSD): 1.08; 95% CI: 1.00, 1.17; P value = 0.05] and similarly for proximal colon cancer, and for vitamin B-12 concentration and higher risk of colorectal cancer (ORSD: 1.12; 95% CI: 1.03, 1.21; P value = 0.01) and similarly for colon cancer. A nominally significant association was also noted for genetically predicted selenium concentration and lower risk of colon cancer (ORSD: 0.98; 95% CI: 0.96, 1.00; P value = 0.05) and similarly for distal colon cancer. These associations were robust to sensitivity analyses. Nominally significant inverse associations were observed for zinc and risk of colorectal and distal colon cancers, but sensitivity analyses could not be performed. None of these findings survived correction for multiple testing. Genetically predicted concentrations of β-carotene, calcium, copper, folate, magnesium, phosphorus, and vitamin B-6 were not associated with disease risk. CONCLUSIONS: These results suggest possible causal associations of circulating iron and vitamin B-12 (positively) and selenium (inversely) with risk of colon cancer.

• Klíčová slova
• Mendelian randomization, colorectal cancer, genes, nutrition, supplements,
• MeSH
• běloši * MeSH
• genetická predispozice k nemoci * MeSH
• kolorektální nádory genetika   MeSH
• lidé MeSH
• mendelovská randomizace * MeSH
• mikroživiny aplikace a dávkování   MeSH
• potravní doplňky MeSH
• rizikové faktory MeSH
• selen krev   MeSH
• studie případů a kontrol MeSH
• vitamin B 12 krev   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• mikroživiny MeSH
• selen MeSH
• vitamin B 12 MeSH

Selenium deficiency is a common nutritional disorder in dairy cattle globally. However, selenium supplementation can lead to selenium toxicity. This study evaluated a novel, low-toxicity selenium supplement, selenitetriglycerides, to determine its efficacy and safety in dairy cows. The study was conducted on 12 Holstein Friesian cows divided in two equal groups (control group without supplementation of selenium and experimental group with supplementation of selenitetriglycerides). Experimental cows (n=6) were orally administered 300 mg/cow/day of selenitetriglycerides for 14 days (days 1-14) and then monitored for a further 14 days (days 15-28). Blood from both groups of cows was sampled for determination of selenium concentrations, activity of aspartate aminotransferase, creatine kinase, lactate dehydrogenase, gamma- -glutamyl transferase, concentrations of triglycerides, cholesterol, non-esterified fatty acids, glucose, total protein, urea, creatinine and hematological parameters. Serum selenium concentrations in the experimental group increased significantly on day 2 (from 64.92±6.89 μg/L to 127.95±13.75 μg/L), peaked on day 7 (266.22±14.21 μg/L) and remained significantly above the initial baseline values (day 1) for 28 days. Serum selenium concentrations in the control group did not change significantly during the 28 day period (65.22 μg/L on 1st day and 64,35 μg/L on 28th day) and were significantly lower than those in the experimental group from day 2 to day 28. The results of clinical examinations, analyses of hematological parameters, and liver and kidney function tests showed that selenitetriglycerides had no adverse effect on the health or on the metabolic or haematological statuses of the cows. These findings indicate that selenitetriglycerides are safe and effective selenium supplements for cattle.

• Klíčová slova
• biochemical parameters, cattle, haematology, selenitetriglycerides, selenium,
• MeSH
• aspartátaminotransferasy krev   metabolismus   MeSH
• cholesterol krev   MeSH
• gama-glutamyltransferasa krev   metabolismus   MeSH
• játra účinky léků   MeSH
• kreatinin krev   MeSH
• kreatinkinasa krev   metabolismus   MeSH
• krevní glukóza MeSH
• krevní proteiny MeSH
• kyseliny mastné neesterifikované krev   MeSH
• L-laktátdehydrogenasa krev   metabolismus   MeSH
• ledviny účinky léků   MeSH
• močovina krev   MeSH
• potravní doplňky MeSH
• selen krev   MeSH
• skot krev   metabolismus   MeSH
• sloučeniny selenu chemie   farmakologie   MeSH
• triglyceridy krev   chemie   farmakologie   MeSH
• zvířata MeSH
• Check Tag
• skot krev   metabolismus   MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• randomizované kontrolované studie veterinární MeSH
• Názvy látek
• aspartátaminotransferasy MeSH
• cholesterol MeSH
• gama-glutamyltransferasa MeSH
• kreatinin MeSH
• kreatinkinasa MeSH
• krevní glukóza MeSH
• krevní proteiny MeSH
• kyseliny mastné neesterifikované MeSH
• L-laktátdehydrogenasa MeSH
• močovina MeSH
• selen MeSH
• sloučeniny selenu MeSH
• triglyceridy MeSH

Dietary selenium (Se) intake is essential for synthesizing selenoproteins that are important in countering oxidative and inflammatory processes linked to colorectal carcinogenesis. However, there is limited knowledge on the selenoprotein expression in colorectal adenoma (CRA) and colorectal cancer (CRC) patients, or the interaction with Se status levels. We studied the expression of seventeen Se pathway genes (including fifteen of the twenty-five human selenoproteins) in RNA extracted from disease-normal colorectal tissue pairs, in the discovery phase of sixty-two CRA/CRC patients from Ireland and a validation cohort of a hundred and five CRC patients from the Czech Republic. Differences in transcript levels between the disease and paired control mucosa were assessed by the Mann-Whitney U-test. GPX2 and TXNRD3 showed a higher expression and GPX3, SELENOP, SELENOS, and SEPHS2 exhibited a lower expression in the disease tissue from adenomas and both cancer groups (p-values from 0.023 to <0.001). In the Czech cohort, up-regulation of GPX1, SELENOH, and SOD2 and down-regulation of SELENBP1, SELENON, and SELENOK (p-values 0.036 to <0.001) was also observed. We further examined the correlation of gene expression with serum Se status (assessed by Se and selenoprotein P, SELENOP) in the Irish patients. While there were no significant correlations with both Se status markers, SELENOF, SELENOK, and TXNRD1 tumor tissue expression positively correlated with Se, while TXNRD2 and TXNRD3 negatively correlated with SELENOP. In an analysis restricted to the larger Czech CRC patient cohort, Cox regression showed no major association of transcript levels with patient survival, except for an association of higher SELENOF gene expression with both a lower disease-free and overall survival. Several selenoproteins were differentially expressed in the disease tissue compared to the normal tissue of both CRA and CRC patients. Altered selenoprotein expression may serve as a marker of functional Se status and colorectal adenoma to cancer progression.

• Klíčová slova
• biomarkers, cancer risk, colorectal adenoma, colorectal cancer, colorectal neoplasm, gene expression, selenium (Se), selenoproteins, selenium status, selenoprotein P,
• MeSH
• adenom krev   genetika   MeSH
• genetické markery MeSH
• glutathionperoxidasa genetika   metabolismus   MeSH
• kohortové studie MeSH
• kolorektální nádory krev   genetika   MeSH
• lidé středního věku MeSH
• lidé MeSH
• proporcionální rizikové modely MeSH
• regulace genové exprese MeSH
• selen krev   MeSH
• selenoprotein P genetika   metabolismus   MeSH
• selenoproteiny genetika   metabolismus   MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• thioredoxin-disulfidreduktasa genetika   metabolismus   MeSH
• thioredoxinreduktasa 1 genetika   metabolismus   MeSH
• Check Tag
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Česká republika MeSH
• Irsko MeSH
• Názvy látek
• genetické markery MeSH
• glutathionperoxidasa MeSH
• GPX2 protein, human MeSH Prohlížeč
• selen MeSH
• SELENOF protein, human MeSH Prohlížeč
• selenoprotein P MeSH
• selenoproteiny MeSH
• thioredoxin-disulfidreduktasa MeSH
• thioredoxinreduktasa 1 MeSH
• TXNRD1 protein, human MeSH Prohlížeč
• TXNRD3 protein, human MeSH Prohlížeč

The aim of this research was to determine the concentrations of cadmium, lead, mercury, and arsenic and the essential elements iron and selenium in the tissues (muscle, kidney, liver, spleen, and fat) of fallow deer (Dama dama L.) without and with supplemental selenium addition. Another aim was to determine the effect of selenium addition on the indicators of oxidative stress, namely, the levels of superoxide dismutase, glutathione peroxidase, glutathione, and vitamin E. The research was carried out with 40 fallow deer during two research periods. Supplemental feed without selenium addition was provided during the first research period, and supplemental feed with added selenium (3 mg/kg) was provided for 60 days during the second research period. The concentration of selenium in tissues was higher in the second research period than in the first research period (in kidney tissue, 0.957 vs. 0.688 mg/kg, P < 0.05). The dietary addition of selenium decreased (P < 0.05) the concentrations of some heavy metals (lead in the spleen = 0.06 vs. 0.27 mg/kg and in the fatty tissue = 0.17 vs. 0.69 mg/kg; arsenic in the muscle tissue = 0.005 vs. 0.014 mg/kg, liver = 0.003 vs. 0.009 mg/kg, spleen = 0.004 vs. 0.013 mg/kg, and fat = 0.008 vs. 0.016 mg/kg). The activity of glutathione peroxidase was significantly higher (P < 0.05) in the second research period than in the first research period (1375.36 vs. 933.23 U/L).

• Klíčová slova
• Antioxidative indicators, Essential trace elements, Fallow deer, Heavy metals, Selenium, Tissues,
• MeSH
• arsen MeSH
• dieta MeSH
• glutathionperoxidasa krev   metabolismus   MeSH
• játra chemie   metabolismus   MeSH
• kadmium MeSH
• ledviny chemie   MeSH
• orgánová specificita účinky léků   MeSH
• rtuť MeSH
• selen analýza   krev   MeSH
• slezina chemie   metabolismus   MeSH
• svaly chemie   metabolismus   MeSH
• vitamin E MeSH
• vysoká zvěř krev   MeSH
• železo MeSH
• zvířata MeSH
• Check Tag
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Chorvatsko MeSH
• Názvy látek
• arsen MeSH
• glutathionperoxidasa MeSH
• kadmium MeSH
• rtuť MeSH
• selen MeSH
• vitamin E MeSH
• železo MeSH

Increased oxidative stress in the brain during the course of Alzheimer's disease (AD) leads to an imbalance of antioxidants and formation of free radical reaction end-products which may be detected in blood as fluorescent lipofuscin-like pigments (LFPs). The aim of this study was to evaluate and compare LFPs with plasma selenium concentrations representing an integral part of the antioxidant system. Plasma samples from subjects with AD dementia (ADD; n=11), mild cognitive impairment (MCI; n=17) and controls (n=12), were collected. The concentration of selenium was measured using atomic absorption spectroscopy. LFPs were analyzed by fluorescence spectroscopy and quantified for different fluorescent maxima and then correlated with plasma selenium. Lower levels of selenium were detected in MCI and ADD patients than in controls (P=0.003 and P=0.049, respectively). Additionally, higher fluorescence intensities of LFPs were observed in MCI patients than in controls in four fluorescence maxima and higher fluorescence intensities were also observed in MCI patients than in ADD patients in three fluorescence maxima, respectively. A negative correlation between selenium concentrations and LFPs fluorescence was observed in the three fluorescence maxima. This is the first study focused on correlation of plasma selenium with specific lipofuscin-like products of oxidative stress in plasma of patients with Alzheimer´s disease and mild cognitive impairment.

• MeSH
• Alzheimerova nemoc krev   diagnóza   patofyziologie   psychologie   MeSH
• biologické markery krev   MeSH
• fluorescenční spektrometrie MeSH
• kognitivní dysfunkce krev   diagnóza   patofyziologie   psychologie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• lipofuscin krev   MeSH
• mozek metabolismus   patofyziologie   MeSH
• oxidační stres * MeSH
• peroxidace lipidů * MeSH
• selen krev   MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• spektrofotometrie atomová MeSH
• studie případů a kontrol MeSH
• testy pro posouzení mentálních funkcí a demence MeSH
• Check Tag
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• srovnávací studie MeSH
• Názvy látek
• biologické markery MeSH
• lipofuscin MeSH
• selen MeSH

The response of nutrient status and biochemical processes in (i) Wistar and (ii) spontaneously hypertensive (SHR) rats upon dietary intake of selenium- (Se-) enriched defatted rapeseed (DRS) and/or vitamin E fortification was examined to assess the health benefit of DRS in animal nutrition. Twenty-four individuals of each type of rat were used: The control group was fed with an untreated diet (Diet A). In Diets B and C, soybean meal was replaced with defatted DRS, which comprised 14% of the total diet. The selenized DRS application resulted in ~3-fold increase of Se content in the diet. Diet C was also fortified with the addition of vitamin E, increasing the natural content by 30%. The Se content of the blood and kidneys tended to increase in the DRS groups, where the changes were significant (P < 0.05) only in the case of SHR rats. The iodine (I) content and the proportion of iodide in rat livers indicated a lower transformation rate of iodide into organoiodine compounds compared to the control. Slight and ambiguous alterations in the antioxidative response of the rat were observed in the DRS groups, but the addition of vitamin E to the diet helped to moderate these effects.

• MeSH
• Brassica rapa * MeSH
• fortifikované potraviny * MeSH
• krysa rodu Rattus MeSH
• ledviny metabolismus   MeSH
• potkani inbrední SHR MeSH
• potkani inbrední WKY MeSH
• potravní doplňky * MeSH
• selen * krev   farmakologie   MeSH
• vitamin E farmakologie   MeSH
• zvířata MeSH
• Check Tag
• krysa rodu Rattus MeSH
• mužské pohlaví MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• selen * MeSH
• vitamin E MeSH

BACKGROUND: The objective of the present study was to determine concentrations of zinc (Zn), copper (Cu), iron (Fe), selenium (Se) in blood plasma and manganese (Mn) in the whole blood in patients with long-term home parenteral nutrition (HPN) in comparison to the control group. PATIENTS AND METHODS: We examined 68 patients (16 men and 52 women) aged from 28 to 68 years on a long-term HPN lasting from 4 to 96 months. The short bowel syndrome was an indication for HPN. The daily doses of Zn, Cu, Fe, Se and Mn in the last 3 months were determined. RESULTS: No significant differences in blood plasma were found for Zn, Cu and Fe in patients with HPN and in the control group (p > 0.05). The concentration of Mn in whole blood was significantly increased in HPN patients (p < 0.0001), while Se concentration in these patients was significantly decreased (p < 0.005). The concentration of Mn in the whole blood of 16 patients with cholestasis was significantly increased compared to the patients without cholestasis (p < 0.001). The Cu concentration was increased with no statistical significance. CONCLUSION: In long-term HPN, the status of trace elements in the patients has to be continually monitored and the daily substitution doses of these elements have to be flexibly adjusted. Dosing schedule needs to be adjusted especially in cases of cholestatic hepatopathy. A discussion about the optimal daily dose of Mn in patients on HPN is appropriate. For clinical practice, the availability of a substitution mixture of trace elements lacking Mn would be advantageous.

• MeSH
• časové faktory MeSH
• deficit železa MeSH
• dospělí MeSH
• intrahepatální cholestáza komplikace   MeSH
• karenční nemoci epidemiologie   etiologie   prevence a kontrola   MeSH
• lidé středního věku MeSH
• lidé MeSH
• mangan analýza   krev   nedostatek   terapeutické užití   MeSH
• měď analýza   krev   nedostatek   terapeutické užití   MeSH
• nutriční stav * MeSH
• parenterální výživa doma škodlivé účinky   MeSH
• prevalence MeSH
• riziko MeSH
• roztoky pro parenterální výživu chemie   MeSH
• selen analýza   krev   nedostatek   terapeutické užití   MeSH
• senioři MeSH
• stopové prvky analýza   krev   nedostatek   terapeutické užití   MeSH
• syndrom krátkého střeva krev   komplikace   patofyziologie   terapie   MeSH
• železo analýza   krev   terapeutické užití   MeSH
• zinek analýza   krev   nedostatek   terapeutické užití   MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Česká republika epidemiologie   MeSH
• Názvy látek
• mangan MeSH
• měď MeSH
• roztoky pro parenterální výživu MeSH
• selen MeSH
• stopové prvky MeSH
• železo MeSH
• zinek MeSH

OBJECTIVE: Low levels of selenium (Se) and glutathione peroxidase (GSHPx), a key selenoenzyme, were documented in systemic inflammatory response syndrome (SIRS) and sepsis, both associated with high mortality. Se supplementation had mixed effects on outcome. We hypothesized that Se supplementation could have a different impact on biomarkers and 28-day mortality in patients with SIRS vs. sepsis. METHODS: Adult patients with SIRS or sepsis were randomized to either high-dose (Se+, n = 75) or standard-dose (Se-, n = 75) Se supplementation. Plasma Se, whole blood GSHPx activity, C-reactive protein (CRP), procalcitonin (PCT), prealbumin, albumin and cholesterol levels were measured serially up to day 14. RESULTS: There was no difference in mortality between Se- (24/75) vs. Se+ group (19/75; p = 0.367) or between SIRS and septic patients (8/26 vs. 35/124; p = 0.794). There was a trend to reduced mortality in SIRS patients in the Se+ vs. Se- group (p = 0.084). Plasma Se levels increased in the Se+ group only in patients with sepsis but not in patients with SIRS. Plasma Se levels correlated with GSHPx. In SIRS/Se+ group, Se correlated only with GSHPx. In SIRS/Se- group, Se correlated with cholesterol but not with other biomarkers. In sepsis patients, Se levels correlated with cholesterol, GSHPx and prealbumin. Cholesterol levels were higher in survivors in the Se- group. CONCLUSIONS: Se levels correlated with GSHPx activity and other nutritional biomarkers with significant differences between SIRS and sepsis groups. High-dose Se supplementation did not affect mortality but a strong trend to decreased mortality in SIRS patients warrants further studies in this population.

• Klíčová slova
• Albumin, Cholesterol, Glutathione peroxidase, Mortality, Outcome, Prealbumin, Selenium, Selenoenzymes, Sepsis, Systemic inflammatory response syndrome,
• MeSH
• biologické markery krev   MeSH
• glutathionperoxidasa krev   MeSH
• kritický stav MeSH
• lidé středního věku MeSH
• lidé MeSH
• míra přežití MeSH
• potravní doplňky MeSH
• selen krev   farmakologie   MeSH
• senioři MeSH
• sepse krev   farmakoterapie   mortalita   MeSH
• syndrom systémové zánětlivé reakce krev   farmakoterapie   mortalita   MeSH
• výsledek terapie MeSH
• zánět krev   MeSH
• Check Tag
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• randomizované kontrolované studie MeSH
• Názvy látek
• biologické markery MeSH
• glutathionperoxidasa MeSH
• selen MeSH

Whole blood selenium, copper, zinc and manganese concentrations of 197 institutionalized senior citizens (46 males, 151 females) aged 61-100 years (mean age 83.6 years) were determined using atomic absorption spectrometry and inductively coupled plasma mass spectrometry from two localities in the Czech Republic (Prague and Teplice) from 2009 through 2011. Geometric means (GM) of whole blood selenium (B-Se), copper (B-Cu), zinc (B-Zn) and manganese (B-Mn) levels were 74.0 μg/l, 941.0 μg/l, 5898.0 μg/l and 10.9 μg/l, respectively. Gender-related differences were found with significantly higher B-Cu levels in women and significantly higher B-Zn levels in men. The percentage of seniors with B-Se levels lower than 56 μg/l (which is equivalent to the critical value of 45 μg/l of Se in serum (S-Se)) was 8.6%. A negative correlation between age and B-Se levels was found. B-Zn positively correlated with serum albumin and prealbumin whereas a negative correlation between age and B-Zn was observed. Seniors with diabetes mellitus and atherosclerosis had higher B-Cu and B-Mn levels, respectively, than those without these diagnoses. The elderly from Prague had significantly higher B-Mn concentrations than those from Teplice. We found no evidence of serious essential elements deficiencies or excesses in the seniors who participated in this study.

• MeSH
• lidé středního věku MeSH
• lidé MeSH
• mangan krev   MeSH
• měď krev   MeSH
• následné studie MeSH
• nutriční stav * MeSH
• referenční hodnoty MeSH
• retrospektivní studie MeSH
• selen krev   MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• spektrofotometrie atomová MeSH
• stárnutí krev   MeSH
• stopové prvky krev   MeSH
• zinek krev   MeSH
• Check Tag
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• multicentrická studie MeSH
• práce podpořená grantem MeSH
• srovnávací studie MeSH
• Geografické názvy
• Česká republika MeSH
• Názvy látek
• mangan MeSH
• měď MeSH
• selen MeSH
• stopové prvky MeSH
• zinek MeSH

Phenylketonuria is an inherited disorder of metabolism of the amino acid phenylalanine caused by a deficit of the enzyme phenylalanine hydroxylase. It is treated with a low-protein diet containing a low content of phenylalanine to prevent mental affection of the patient. Because of the restricted intake of high-biologic-value protein, patients with phenylketonuria may have lower than normal serum concentrations of pre-albumin, selenium, zinc and iron. The objective of the present study was to assess the compliance of our phenylketonuric (PKU) and hyperphenylalaninemic (HPA) patients; to determine the concentration of serum pre-albumin, selenium, zinc and iron to discover the potential correlation between the amount of proteins in food and their metabolic control. We studied 174 patients of which 113 were children (age 1-18), 60 with PKU and 53 with HPA and 61 were adults (age 18-42), 51 with PKU and 10 with HPA. We did not prove a statistically significant difference in the concentration of serum pre-albumin, zinc and iron among the respective groups. We proved statistically significant difference in serum selenium concentrations of adult PKU and HPA patients (p = 0.006; Mann-Whitney U test). These results suggest that controlled low-protein diet in phenylketonuria and hyperphenylalaninemia may cause serum selenium deficiency in adult patients.

• MeSH
• dítě MeSH
• dospělí MeSH
• fenylketonurie * krev   dietoterapie   MeSH
• kojenec MeSH
• lidé MeSH
• mladiství MeSH
• nízkoproteinová dieta škodlivé účinky   MeSH
• předškolní dítě MeSH
• prospektivní studie MeSH
• selen * krev   nedostatek   MeSH
• Check Tag
• dítě MeSH
• dospělí MeSH
• kojenec MeSH
• lidé MeSH
• mladiství MeSH
• mužské pohlaví MeSH
• předškolní dítě MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• klinické zkoušky MeSH
• multicentrická studie MeSH
• práce podpořená grantem MeSH
• Geografické názvy
• Česká republika MeSH
• Názvy látek
• selen * MeSH